According to a new report, published by KBV research, The Global Coated Endotracheal Tube Market size is expected to reach $238.2 million by 2030, rising at a market growth of 6.1% CAGR during the forecast period. In the year 2022, the market attained a volume of 9,493.1 thousand units experiencing a growth of 8.9% (2019-2022).
The Orotracheal segment is registering a CAGR of 5.8 % during the forecast period. As orotracheal intubation involves passing the tube through the mouth, coated tubes can contribute to smoother insertion, minimizing trauma and potentially reducing the risk of complications. This can drive the preference for coated tubes in procedures involving orotracheal intubation. Coated endotracheal tubes, with their infection-preventing properties and reduced trauma, are beneficial for high-risk patients. This includes individuals with compromised immune systems or preexisting respiratory conditions, contributing to the broader adoption of coated tubes in orotracheal intubation.
The Hospitals segment led the Global Coated Endotracheal Tube Market by End User in 2022; thereby, achieving a market value of $135 Million by 2030. As key healthcare institutions, hospitals prioritize patient safety and positive clinical outcomes. The adoption of coated tubes contributes to a reduction in complications, enhancing overall patient care and recovery. Coated endotracheal tubes align with a patient-centric care approach, improving the patient experience and minimizing discomfort. Hospitals prioritizing patient-centered care recognize the value of coated tubes in enhancing the overall patient experience during airway management. This approach can contribute to higher patient satisfaction and positive feedback.
The Anesthesia segment is growing at a CAGR of 5.7 % during the forecast period. In anesthesia management, a smooth and efficient intubation process is crucial. Coated tubes reduce resistance during insertion, contributing to a smoother intubation experience for healthcare providers and patients. Coated endotracheal tubes contribute to a gentler interaction with airway tissues, reducing the risk of complications. Integrating smart features enhances the capabilities of coated endotracheal tubes in the anesthesia segment. Real-time monitoring provides valuable data to anesthesia providers, facilitating prompt interventions and contributing to improved patient care.
The North America region dominated the Global Coated Endotracheal Tube Market by Region in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $78.2 Million by 2030. The Europe region is anticipated to grow at a CAGR of 5.9% during (2023 - 2030). Additionally, The Asia Pacific region would witness a CAGR of 7% during (2023 - 2030).
Full Report: https://www.kbvresearch.com/coated-endotracheal-tube-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Sonoma Pharmaceuticals Inc., Becton, Dickinson, and Company, Bactiguard Holding AB (publ), Sharklet Technologies, Inc., Medline Industries, LP, N8 Medical, LLC, Armstrong Medical Ltd (Eakin Healthcare Ltd), Teleflex, Inc. and Venner Medical (Deutschland) GmbH
By Intubation (Volume, Thousand Units, USD Million, 2019-2030)
By End User (Volume, Thousand Units, USD Million, 2019-2030)
By Application (Volume, Thousand Units, USD Million, 2019-2030)
By Geography (Volume, Thousand Units, USD Million, 2019-2030)
Companies Profiled
Unique Offerings 
